HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) vs Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Side-by-side comparison of two grants.
| Attribute | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) | Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $100K | $100K |
| Deadline | Closes in 2 days | Closes 2028-09-07 |
| Region | US | US |
| Sector | Education | Education |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | researchers, students, government | researchers, students |